Staphylococcus aureus gyrA and gyrB genes, which encode the DNA gyrase A and B proteins, have been isolated and found to map contiguously. DNA sequence analysis revealed close homology between the S. aureus gyrase subunits and their counterparts in Bacillus subtilis and Escherichia coli, including several conserved amino acid residues whose substitution in E. coli confers resistance to 4-quinolones. These results are discussed in regard to quinolone resistance mechanisms in S. aureus.
Staphylococcal infections, particularly those involving methicillin-resistant Staphylococcus aureus, are a serious medical problem (17) . Treatment with ciprofloxacin and other 4-quinolones, which are inhibitors of the essential bacterial enzyme DNA gyrase (7, 35) , has been effective but has led to the widespread emergence of quinolone-resistant Staphylococcus strains (14, 23, (25) (26) (27) .
Studies with Escherichia coli have shown that quinolones rapidly arrest DNA synthesis in vivo and inhibit ATPdependent DNA supercoiling by purified DNA gyrase (3, 6, 8) . Mutations conferring quinolone resistance in E. coli map largely in the unlinked gyrA or (less often) gyrB genes, which encode the A and B subunits of the A2B2 gyrase complex (2, 4, 6, 11, 36, 37) . The gyrase A subunits are known to mediate transient DNA breakage and reunion during catalysis, a process interrupted by 4-quinolones, whereas the B subunits bind and hydrolyze ATP, providing the energetic requirement for DNA supercoiling (12, 19, 29, 34) . Although S. aureus DNA gyrase has been partially purified by us and by others (31) , abundant protease and nuclease activities present in crude extracts have hampered the study of the enzyme and its role in quinolone action and resistance (our unpublished results). We have therefore followed a genetic approach to the study of S. aureus gyrase, and we describe here the isolation and initial sequence characterization of the S. aureus gyrA and gyrB genes.
For these studies, we used S. aureus 81231, a methicillinsensitive coagulase-positive clinical isolate taken from the neck wound of a patient at this hospital in 1987. The strain was susceptible to ciprofloxacin: there was no growth on brain heart infusion medium plates containing the drug at 0.5 ,ug/ml. Genomic DNA from the strain (16) was found to hybridize by Southern blotting on Hybond-N filters (28) to a 1.7-kilobase (kb) BamHI-SacI DNA fragment from within the Bacillus subtilis gyrB gene (21) , which was isolated from plasmid pML2 (15) and radiolabeled by random priming with the Amersham Multiprime labeling kit (Fig. 1 (data not shown) yielded a restriction map for the gyrB homolog in S. aureus 81231 (Fig. 2) . Moreover, the absence of hybridization to E. coli DNA (Fig. 1) (10) . Ampicillin-resistant transformants were screened (following plasmid amplification on chloramphenicol plates) by low-stringency colony hybridization to the B. subtilis gyrB probe (9) . Of the 35 strongly positive clones found in the library of 2,400 transformants, 7 were analyzed and found to contain pBR322 bearing the desired 2.4-kb insert.
The insert from one plasmid, pRH1, was 3' end labeled with 32p at its EcoRI or HindlIl ends or at internal ClaI or XbaI sites, and the labeled strands were partially sequenced by the method of Maxam and Gilbert (18) . Open reading frames deduced from DNA sequences at the EcoRI, XbaI, and 5' Clal sites (Fig. 2) (21, 30, 37 ) (see below). These results indicated that the gyrB and gyrA genes are contiguous in S. aureus, as in B. subtilis, another gram-positive bacterium (15, 21) . Because of the close similarity to B. subtilis genes, the likely extent of the S. aureus gyrB and gyrA genes could be estimated (Fig. 2) . High-stringency screening of appropriate size-selected S. aureus DNA libraries in plasmid pUC19 with the 2.4-kb insert from pRH1 led to the isolation of plasmids pRH2 and pRH3, which carry the overlapping 3.5-kb XbaI-EcoRI and 6.5-kb HindIlI fragments that span the gyrB-gyrA locus (Fig.  2) .
To 30, 36, 37) . In panel B, the conserved catalytic tyrosine, Tyr-122, is indicated in capitals (13) . *, Residues in the gyrase A protein, e.g., Ser-83, whose substitution confers resistance to quinolones in E.
coli (2, 37) .
Arg-Tyr-Thr-Glu, has been shown in the E. coli A protein to carry the catalytic tyrosine, Tyr-122, responsible for transient DNA scission via a DNA-phosphotyrosine intermediate (13) .
Second, there is conservation of five residues in the gyrase A and B subunits whose substitution in E. coli is responsible for bacterial resistance to nalidixic acid and the 4-quinolones; these residues are Ala-67, Ser-83, and Gln-106 in the gyrase A protein (Fig. 4B, asterisks) and the gyrase B residues Asp-426 and Lys-447 (data not shown) (2, 35, 37 (20, 32) . Second, although there is a potential Shine-Dalgarno sequence, appropriately located 5' of the gyrA gene (Fig. 3) , from which translation of gyrA message could take place, no promoter sequences are apparent. Thus, the lack of obvious transcription initiation and termination signals in the intergenic region admits the possibility of coordinate control. The availability of the cloned gyrB and gyrA genes will enable their expression and other aspects of gyrase function in S. aureus to be elucidated. 
